ATE241991T1 - Synergistische zusammensetzung, die daunorubicin derivate und antimetabolite enthält - Google Patents
Synergistische zusammensetzung, die daunorubicin derivate und antimetabolite enthältInfo
- Publication number
- ATE241991T1 ATE241991T1 AT00949297T AT00949297T ATE241991T1 AT E241991 T1 ATE241991 T1 AT E241991T1 AT 00949297 T AT00949297 T AT 00949297T AT 00949297 T AT00949297 T AT 00949297T AT E241991 T1 ATE241991 T1 AT E241991T1
- Authority
- AT
- Austria
- Prior art keywords
- antimetabolites
- composition containing
- synergistic composition
- daunorubicin derivatives
- containing daunorubicin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9916882.5A GB9916882D0 (en) | 1999-07-19 | 1999-07-19 | Antitumor synergistic composition |
| PCT/EP2000/006545 WO2001005382A1 (en) | 1999-07-19 | 2000-07-10 | Synergistic composition comprising daunorubicin derivatives and antimetabolite compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE241991T1 true ATE241991T1 (de) | 2003-06-15 |
Family
ID=10857494
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00949297T ATE241991T1 (de) | 1999-07-19 | 2000-07-10 | Synergistische zusammensetzung, die daunorubicin derivate und antimetabolite enthält |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1200099B1 (de) |
| JP (1) | JP2003504394A (de) |
| AT (1) | ATE241991T1 (de) |
| AU (1) | AU6271100A (de) |
| DE (1) | DE60003189T2 (de) |
| DK (1) | DK1200099T3 (de) |
| ES (1) | ES2195922T3 (de) |
| GB (1) | GB9916882D0 (de) |
| PT (1) | PT1200099E (de) |
| WO (1) | WO2001005382A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0114654D0 (en) * | 2001-06-15 | 2001-08-08 | Pharmacia & Upjohn Spa | Anti-tumor compound |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4853221A (en) * | 1980-11-13 | 1989-08-01 | Warner-Lambert Company | Method for treating non-small cell lung cancer, head and neck cancers and breast cancer |
| US5919816A (en) * | 1994-11-14 | 1999-07-06 | Bionumerik Pharmaceuticals, Inc. | Formulations and methods of reducing toxicity of antineoplastic agents |
| GB9806324D0 (en) * | 1998-03-24 | 1998-05-20 | Pharmacia & Upjohn Spa | Antitumour synergetic composition |
| GB9904386D0 (en) * | 1999-02-25 | 1999-04-21 | Pharmacia & Upjohn Spa | Antitumour synergistic composition |
| GB9904387D0 (en) * | 1999-02-25 | 1999-04-21 | Pharmacia & Upjohn Spa | Antitumour synergistic composition |
| GB9909925D0 (en) * | 1999-04-29 | 1999-06-30 | Pharmacia & Upjohn Spa | Combined preparations comprising anthracycline derivatives |
-
1999
- 1999-07-19 GB GBGB9916882.5A patent/GB9916882D0/en not_active Ceased
-
2000
- 2000-07-10 WO PCT/EP2000/006545 patent/WO2001005382A1/en active IP Right Grant
- 2000-07-10 ES ES00949297T patent/ES2195922T3/es not_active Expired - Lifetime
- 2000-07-10 JP JP2001510439A patent/JP2003504394A/ja not_active Withdrawn
- 2000-07-10 EP EP00949297A patent/EP1200099B1/de not_active Expired - Lifetime
- 2000-07-10 AU AU62711/00A patent/AU6271100A/en not_active Abandoned
- 2000-07-10 AT AT00949297T patent/ATE241991T1/de not_active IP Right Cessation
- 2000-07-10 PT PT00949297T patent/PT1200099E/pt unknown
- 2000-07-10 DK DK00949297T patent/DK1200099T3/da active
- 2000-07-10 DE DE60003189T patent/DE60003189T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU6271100A (en) | 2001-02-05 |
| JP2003504394A (ja) | 2003-02-04 |
| EP1200099A1 (de) | 2002-05-02 |
| DE60003189T2 (de) | 2003-12-18 |
| ES2195922T3 (es) | 2003-12-16 |
| WO2001005382A8 (en) | 2001-04-12 |
| WO2001005382A1 (en) | 2001-01-25 |
| GB9916882D0 (en) | 1999-09-22 |
| EP1200099B1 (de) | 2003-06-04 |
| DK1200099T3 (da) | 2003-07-21 |
| PT1200099E (pt) | 2003-08-29 |
| DE60003189D1 (de) | 2003-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0008453A (pt) | Composição sinergìstica anti-tumoral | |
| GB0025173D0 (en) | Therapeutic agents | |
| DE60112974D1 (en) | Carbolinderivate | |
| BG106586A (en) | Pyrazolopyramidines as therapeutic agents | |
| BG105270A (en) | Tetrahydropyridoethers | |
| PT815087E (pt) | Derivados de fenilo trissubstituidos | |
| IL149402A0 (en) | Arylamine derivatives and their use as anti-telomerase agent | |
| DE60216233D1 (en) | Carbolinderivate | |
| PA8486401A1 (es) | Antibioticos cetolidos carbamato y carbazato | |
| MXPA03010761A (es) | Combinaciones farmaceuticas. | |
| BR9908391A (pt) | Composição antitumural contendo uma combinação sinergìstica de um derivado de antraciclina com um derivado de camptotecina | |
| HRPK20030734B3 (en) | A combination comprising combretastatin and anticancer agents | |
| AR032432A1 (es) | Combinaciones oncoliticas para el tratamiento de cancer | |
| BG102250A (en) | The use of marigold-extracted glycosides for the treatment of psoriasis | |
| DE69907926D1 (de) | 1,2,4-triazol-3-thion verbindungen | |
| CY1106713T1 (el) | Συνδυασμενη θεραπεια εναντιον καρκινωματων η οποια περιλαμβανει παραγωγα υποκαταστημενης ακρυλοϋλ δισταμυσινης και αλκυλιωτικους παραγοντες | |
| BR0309996A (pt) | Composto, composição farmacêutica, método de tratar ou melhorar doenças ou condições proliferativas, uso de um composto, e, método de tratar ou melhorar doenças inflamatórias | |
| ATE241991T1 (de) | Synergistische zusammensetzung, die daunorubicin derivate und antimetabolite enthält | |
| YU46302A (sh) | Supstituisani piroli | |
| HK1054506A1 (en) | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites | |
| BR0008454A (pt) | Composição sinergìstica anti-tumoral | |
| PT1551850E (pt) | 2 oxo-voruscharina e seus derivados | |
| TWI231815B (en) | Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1200099 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |